Meanwhile, the STAREE trial will assess the efficacy of atorvastatin 40 mg daily versus
These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more
Types of cholesterol-lowering drugs
The study is aimed at comparing the lipid-lowering/increasing effects of 7 different statins in patients with dyslipidemia, cardiovascular diseases, or diabetes
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e
Statins lower serum cholesterol levels and may thus improve the cardiovascular risk in PBC patients
Although different types of statins ought to have similar efficacy treating dyslipidemia, atorvastatin was found to be popular and most commonly prescribed one
ESC Clinical Practice Guidelines
amlodipine, atorvastatin drug combination
RESIDUAL RISK OF CARDIOVASCULAR DISEASE AND THE ROLE OF ATHEROGENIC DYSLIPIDEMIA
Both Europe and US guidelines recommend a statin, with Europe having a target of ; 100 mg/dl, the US a moderate-intensity statin, and each recommending considering lipid and other enhancers
Diabetic dyslipidemia is a cluster of lipoprotein abnormalities characterized by increased triglyceride level, decreased high-density lipoprotein-cholesterol levels and increase in small dense low-density lipoprotein (LDL) particles
statin therapy; and patient preferences and values in shared decision-making
Background: Various experimental studies demonstrated that atorvastatin exerted additive effects with anticancer drugs to impair tumor growth, delay relapse, and prolong survival time in lung cancer
For a detailed discussion of statin safety and management of statin-associated side effects, please refer to Section 5 of the 2018 Cholesterol Clinical Practice Guidelines
Statin use and dyslipidemia appear to be broadly associated with dry eye disease (DED), according to a large retrospective study of patients treated at the University of North Carolina (UNC) ophthalmic clinics